英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

dyadic    
dyadic
二元的



安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Dyadic - Dyadic
    Dyadic has a growing suite of vaccines, antibodies, and other therapeutic treatments available for licensing Additional recombinant protein products for diagnostics, cell culture, food applications, and reagent research grade materials are currently in development such as recombinant human serum albumin
  • Dyadic Reports 2024 Year-End Financial Results and Business Updates
    JUPITER, Fla , March 26, 2025 — Dyadic International, Inc (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non- pharmaceutical applications including food
  • Dyadic Reports First Quarter 2025 Financial Results and Highlights of . . .
    Dyadic’s C1 microbial expression technology is expected to be among the platform technologies evaluated, highlighting its potential to accelerate development and reducing the cost of manufacturing vaccines and antibodies at scale On March 23, 2025, CEPI announced a grant of $2 6 million to Uvax Bio
  • About Us - Dyadic
    Dyadic International, Inc (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical and bio-industrial products for human and animal health and alternative
  • Dyadic Announces Third Quarter 2024 Financial Results and Strategic . . .
    JUPITER, Fla , Nov 12, 2024 — Dyadic International, Inc (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as non- pharmaceutical applications including food
  • Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J. P . . .
    Dyadic’s microbial gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila) Our lead platform, the C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is currently used to
  • Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal . . .
    JUPITER, Fla , Nov 21, 2024 — Dyadic International, Inc (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the Gates Foundation for the cell line development of monoclonal antibodies (mAbs) targeting respiratory syncytial virus (RSV) and malaria utilizing the company’s
  • Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift . . .
    JUPITER, Fla , June 02, 2025 — Dyadic International, Inc (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI) today announced a leadership change as part of its ongoing strategic shift to evolve into a revenue-generating provider of ancillary recombinant protein products supporting the life sciences, nutrition
  • C1-cell Protein Production Platform - Dyadic
    Dyadic’s naturally derived C1 cells went through random mutagenesis This development brought about highly beneficial changes and transformed the shape of the C1 cells, from long strands to short, grain-sized sections
  • Dyadic to Present at World Vaccine Congress | Washington
    Dyadic’s microbial gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila) Our lead platform, the C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is currently used to





中文字典-英文字典  2005-2009